Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.38M Sell
45,000
-2,345
-5% -$178K 0.08% 106
2021
Q2
$3.68M Buy
47,345
+592
+1% +$44K 0.09% 97
2021
Q1
$3.44M Sell
46,753
-870
-2% -$64.2K 0.09% 88
2020
Q4
$3.72M Buy
47,623
+5,062
+12% +$387K 0.11% 77
2020
Q3
$3.37M Buy
42,561
+424
+1% +$33.2K 0.12% 63
2020
Q2
$3.11M Sell
42,137
-179
-0.4% -$13.5K 0.13% 53
2020
Q1
$3.11M Buy
42,316
+889
+2% +$69.9K 0.18% 47
2019
Q4
$3.6M Buy
41,427
+1,820
+5% +$149K 0.17% 52
2019
Q3
$3.18M Sell
39,607
-1,179
-3% -$94.5K 0.16% 49
2019
Q2
$3.26M Buy
40,786
+3,775
+10% +$289K 0.17% 47
2019
Q1
$2.94M Sell
37,011
-696
-2% -$52.1K 0.15% 47
2018
Q4
$2.75M Buy
37,707
+1,666
+5% +$118K 0.16% 51
2018
Q3
$2.44M Buy
36,041
+7,350
+26% +$468K 0.15% 56
2018
Q2
$1.66M Buy
28,691
+3,245
+13% +$183K 0.12% 73
2018
Q1
$1.32M Sell
25,446
-1,839
-7% -$99.3K 0.09% 108
2017
Q4
$1.47M Sell
27,285
-1,248
-4% -$69.2K 0.1% 103
2017
Q3
$1.74M Sell
28,533
-665
-2% -$40.3K 0.14% 68
2017
Q2
$1.79M Sell
29,198
-6,062
-17% -$369K 0.16% 54
2017
Q1
$2.14M Sell
35,260
-155
-0.4% -$9.4K 0.18% 44
2016
Q4
$1.99M Buy
35,415
+33
+0.1% +$1.93K 0.18% 44
2016
Q3
$2.11M Buy
35,382
+3,222
+10% +$188K 0.19% 42
2016
Q2
$1.77M Buy
32,160
+2,252
+8% +$120K 0.17% 46
2016
Q1
$1.51M Buy
29,908
+1,246
+4% +$61K 0.15% 48
2015
Q4
$1.45M Sell
28,662
-2,464
-8% -$124K 0.13% 57
2015
Q3
$1.47M Buy
31,126
+2,694
+9% +$143K 0.15% 52
2015
Q2
$1.54M Buy
28,432
+174
+0.6% +$9.76K 0.15% 58
2015
Q1
$1.55M Sell
28,258
-495
-2% -$28K 0.15% 57
2014
Q4
$1.56M Buy
28,753
+2,573
+10% +$143K 0.16% 53
2014
Q3
$1.48M Buy
26,180
+2,245
+9% +$126K 0.15% 55
2014
Q2
$1.32M Buy
23,935
+1,069
+5% +$58.3K 0.15% 60
2014
Q1
$1.24M Buy
22,866
+892
+4% +$46.2K 0.16% 55
2013
Q4
$1.05M Buy
21,974
+506
+2% +$23.1K 0.15% 60
2013
Q3
$975K Buy
21,468
+2,772
+15% +$127K 0.15% 59
2013
Q2
$829K Buy
+18,696
New +$835K 0.15% 56

Other funds holding MRK

Homrich & Berg's MRK Position: Q3 2021 in Review

Homrich & Berg reduced its Merck (MRK) stake by 5% in Q3 2021, selling an estimated $178K and leaving 45,000 shares worth $3.38M. The position accounts for 0.08% of the portfolio, ranked #106.

Homrich & Berg first reported a position in MRK in Q2 2013 and has held it in 34 quarters since. The position peaked at $3.72M in Q4 2020. 2,647 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • Homrich & Berg held 45,000 shares of Merck worth $3.38M as of Q3 2021.
  • Homrich & Berg sold 2,345 Merck shares in Q3 2021, an estimated $178K.
  • Merck made up 0.08% of Homrich & Berg's portfolio in Q3 2021, its #106 holding.
  • Homrich & Berg first reported a position in Merck in Q2 2013 and has held it in 34 quarters since.
  • Homrich & Berg's Merck position peaked at $3.72M in Q4 2020.
  • 2,647 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.